Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection.
Hagiwara S, Nishida N, Ida H, Ueshima K, Minami Y, Takita M, Aoki T, Morita M, Chishina H, Komeda Y, Yoshida A, Hayashi H, Nakagawa K, Kudo M.
Hagiwara S, et al. Among authors: minami y.
Hepatol Res. 2022 Sep;52(9):754-761. doi: 10.1111/hepr.13798. Epub 2022 Jun 15.
Hepatol Res. 2022.
PMID: 35635496